Deborah M. Proctor

Deborah M. Proctor

Auto-generated profile, based on publicly available information

Deborah M. Proctor

ToxStrategies LLC

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Toxicology
Verified
Journal Article
Closed access
DPDeborah M. Proctor
Deborah M. Proctor
MSMina Suh
Mina Suh
SCSharan L. Campleman
Sharan L. Campleman
CTChad M. Thompson
Chad M. Thompson

1 May 2019 in Toxicology Letters
Verified
Journal Article
Closed access
JRJulia E Rager
Julia E Rager
MSMina Suh
Mina Suh
GCGrace A. Chappell
Grace A. Chappell
CTChad M. Thompson
Chad M. Thompson
DPDeborah M. Proctor
Deborah M. Proctor

16 December 2015 in Journal of Exposure Science & Environmental Epidemiology
Verified
Journal Article
Open access
DPDeborah M Proctor
Deborah M Proctor
MSMina Suh
Mina Suh
LMLiz Mittal
Liz Mittal
SHShawn Hirsch
Shawn Hirsch
RSRaydel Valdes Salgado
Raydel Valdes Salgado
KCKenny Crump
Kenny Crump
The exposure-response for hexavalent chromium (Cr(VI))-induced lung cancer among workers of the Painesville Ohio chromate production facility has been used internationally for quantitative risk assessment of environmental and occupational exposures to airborne Cr(VI). We updated the mortality of 714 Painesville workers (including 198 short-term workers) through December 2011, reconstructed exposures, and conducted exposure-response modeling using Poisson and Cox regressions to provide quantitative lung cancer risk estimates. The average length of follow-up was 34.4 years with 24,535 person-years at risk. Lung cancer was significantly increased for the cohort (standardized mortality ratio (SMR)=186; 95% confidence interval (CI) 145–228), for those hired before 1959, those with >30-year tenure, and those with cumulative exposure >1.41 mg/m3-years or highest monthly exposures >0.26 mg/m3. Of the models assessed, the linear Cox model with unlagged cumulative exposure provided the best fit and was preferred. Smoking and age at hire were also significant predictors of lung cancer mortality. Adjusting for these variables, the occupational unit risk was 0.00166 (95% CI 0.000713–0.00349), and the environmental unit risk was 0.00832 (95% CI 0.00359–0.0174), which are 20% and 15% lower, respectively, than values developed in a previous study of this cohort.

1 August 2016 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
MSMina Suh
Mina Suh
CTChad M. Thompson
Chad M. Thompson
GBGregory P. Brorby
Gregory P. Brorby
LMLiz Mittal
Liz Mittal
DPDeborah M. Proctor
Deborah M. Proctor

1 June 2018 in Toxicology
Verified
Journal Article
Open access
MSMina Suh
Mina Suh
DPDeborah Proctor
Deborah Proctor
GCGrace Chappell
Grace Chappell
JRJulia Rager
Julia Rager
CTChad Thompson
Chad Thompson
KWKarin Wiench
Karin Wiench
Lower alkyl acrylate monomers include methyl-, ethyl-, n-butyl-, and 2-ethylhexyl acrylate. These acrylates are used in the manufacture of acrylic polymers and copolymers for plastics, food packaging, adhesives, and cosmetic formulations. Although there is limited potential for human environmental exposure, occupational exposure can occur via inhalation and dermal contact. Recently, new genotoxicity data have been generated, along with in silico and in vitro read-cross analyses, for these acrylates. The availability of high-throughput screening (HTS) data through the ToxCast™/Tox21 databases allows for consideration of computational toxicology and organization of these data according to the ten key characteristics of carcinogens. Therefore, we conducted a comprehensive review to evaluate the mechanistic, toxicokinetic, animal, and human data, including HTS data, for characterizing the potential carcinogenicity, mutagenicity, and genotoxicity of these acrylates. Toxicokinetic data demonstrate that these acrylates are metabolized rapidly by carboxylesterase hydrolysis and conjugation with glutathione. HTS data demonstrated an overall lack of bioactivity in cancer-related pathways. Overall, the genotoxicity and mutagenicity data support a cytotoxic, non-genotoxic mechanism for these acrylates. Cancer bioassay studies conducted by the oral, dermal, and inhalation routes in animal models with these acrylates did not show any increase in tumor incidence, with two exceptions. At high doses, and secondary to chronic site-of-contact irritation and corrosion, rodent forestomach tumors were induced by oral gavage dosing with ethyl acrylate, and skin tumors were observed following chronic dermal dosing with 2-ethylhexyl acrylate in C3H/HeJ inbred mice (a strain with deficiencies in wound healing), but not in the outbred NMRI strain. For both dermal and forestomach cancers, tumorigenesis is secondary to high doses and long-term tissue damage, shown to be reversible. With evidence that these chemicals are not genotoxic, and that they cause forestomach and dermal tumors through chronic irritation and regenerative proliferation mechanisms, these acrylates are unlikely to pose a human cancer hazard.

1 October 2012 in Chemosphere
Verified
Journal Article
Open access
DPDeborah M. Proctor
Deborah M. Proctor
MSMina Suh
Mina Suh
LALesa L. Aylward
Lesa L. Aylward
CKChristopher R. Kirman
Christopher R. Kirman
MHMark A. Harris
Mark A. Harris
SHSean M. Hays
Sean M. Hays
Reduction of hexavalent chromium (Cr(VI)) to trivalent chromium (Cr(III)) in the stomach prior to absorption is a well-recognized detoxification process thought to limit the toxicity of ingested Cr(VI). However, administration of high concentrations of Cr(VI) in drinking water cause mouse small intestinal tumors, and quantitative measures of Cr(VI) reduction rate and capacity for rodent stomach contents are needed for interspecies extrapolation using physiologically-based toxicokinetic (PBTK) models. Ex vivo studies using stomach contents of rats and mice were conducted to quantify Cr(VI) reduction rate and capacity for loading rates (1-400 mg Cr(VI)L(-1) stomach contents) in the range of recent bioassays. Cr(VI) reduction was measured with speciated isotope dilution mass spectrometry to quantify dynamic Cr(VI) and Cr(III) concentrations in stomach contents at select time points over 1 h. Cr(VI) reduction followed mixed second-order kinetics, dependent upon concentrations of both Cr(VI) and the native reducing agents. Approximately 16 mg Cr(VI)-equivalents of reducing capacity per L of fed stomach contents (containing gastric secretions, saliva, water and food) was found for both species. The second-order rate constants were 0.2 and 0.3 L mg(-1) h(-1) for mice and rats, respectively. These findings support that, at the doses that caused cancer in the mouse small intestine (≥ 20 mg Cr(VI)L(-1) in drinking water), the reducing capacity of stomach contents was likely exceeded. Thus, for extrapolation of target tissue dose in risk assessment, PBTK models are necessary to account for competing kinetic rates including second order capacity-limited reduction of Cr(VI) to Cr(III).